{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:01:55Z","timestamp":1790362915159,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union\u2019s Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018\u201305501"],"award-info":[{"award-number":["2018\u201305501"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","award":["RIF14-0078"],"award-info":[{"award-number":["RIF14-0078"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cmi.2020.12.004","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T18:49:04Z","timestamp":1607712544000},"page":"1315-1321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Katja","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Aranzana-Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shariatgorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Haldimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Platzack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diarmaid","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per E.","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik C.","family":"B\u00f6ttger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven N.","family":"Hobbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.12.004_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2020.12.004_bib2","series-title":"Antibiotic resistance threats in the United States","year":"2019"},{"key":"10.1016\/j.cmi.2020.12.004_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01110-18","article-title":"New treatment options against carbapenem-resistant Acinetobacter baumannii infections","volume":"63","author":"Isler","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.12.004_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00028-2018","article-title":"Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia","volume":"4","author":"Torres","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.cmi.2020.12.004_bib5","series-title":"Annual report of the European antimicrobial resistance surveillance network (EARS-Net) 2017. Stockholm","first-page":"ECDC2018","article-title":"Surveillance of antimicrobial resistance in Europe","year":"2018"},{"key":"10.1016\/j.cmi.2020.12.004_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.12.004_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.cmi.2020.12.004_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cmi.2020.12.004_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fmicb.2020.00668","article-title":"Abundance of colistin-resistant, OXA-23- and ArmA-producing Acinetobacter baumannii belonging to international Clone 2 in Greece","volume":"11","author":"Palmieri","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2020.12.004_bib10","doi-asserted-by":"crossref","first-page":"106019","DOI":"10.1016\/j.ijantimicag.2020.106019","article-title":"Co-occurrence of aminoglycoside and \u03b2-lactam resistance mechanisms in aminoglycoside-non-susceptible Escherichia coli isolated in the Zurich area, Switzerland","author":"Bodendoerfer","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.12.004_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41579-020-0340-0","article-title":"Critical analysis of antibacterial agents in clinical development","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2020.12.004_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/jac\/dky546","article-title":"In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii","volume":"74","author":"Juhas","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.12.004_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176133","article-title":"Epidemiologic, phenotypic, and structural characterization of aminoglycoside-resistance gene aac(3)-IV","volume":"21","author":"Plattner","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cmi.2020.12.004_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.diagmicrobio.2017.03.006","article-title":"In vitro apramycin activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"88","author":"Kang","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2020.12.004_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/mdr.2019.0075","article-title":"Dissemination of international clone II Acinetobacter baumannii strains coproducing OXA-23 carbapenemase and 16S rRNA methylase ArmA in Athens, Greece","volume":"26","author":"Nafplioti","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2020.12.004_bib16","series-title":"Antibiotic resistance isolate bank","author":"CDC & FDA","year":"2020"},{"key":"10.1016\/j.cmi.2020.12.004_bib17","article-title":"Model-informed drug development for antimicrobials: translational PK and PKPD modelling to predict an efficacious human dose for apramycin","author":"Sou","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cmi.2020.12.004_bib18","first-page":"1","article-title":"Susceptibility patterns of multidrug-resistant Acinetobacter baumannii","author":"Konca","year":"2020","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.cmi.2020.12.004_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2018.11.008","article-title":"Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies","volume":"94","author":"Oliota","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2020.12.004_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01374-19","article-title":"Synergistic combinations and repurposed antibiotics active against the pandrug-resistant Klebsiella pneumoniae Nevada Strain","volume":"63","author":"Brennan-Krohn","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.12.004_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fmicb.2020.00425","article-title":"In\u00a0vitro activity of apramycin against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates","volume":"11","author":"Hao","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2020.12.004_bib22","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/jac\/dkx322","article-title":"High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial","volume":"72","author":"Nowak","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.12.004_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02585-17","article-title":"Efficacy of apramycin against multidrug-resistant Acinetobacter baumannii in the murine neutropenic thigh model","volume":"62","author":"Kang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.12.004_bib24","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1093\/jac\/dky239","article-title":"Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients","volume":"73","author":"Boisson","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.12.004_bib25","article-title":"A\u00a0double-blind, randomized, placebo-controlled study to assess the safety, tolerability, plasma pharmacokinetics and lung penetration of intravenous plazomicin in healthy subjects: poster 1637","author":"Cass","year":"2013","journal-title":"Abstr Eur Congr Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2020.12.004_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijantimicag.2018.11.011","article-title":"Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: a systematic review","volume":"53","author":"Heffernan","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.12.004_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2125.1999.00938.x","article-title":"Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily","volume":"47","author":"Kirkpatrick","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cmi.2020.12.004_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijantimicag.2003.07.010","article-title":"Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing","volume":"23","author":"Xuan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.12.004_bib29","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.1204073109","article-title":"Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin","volume":"109","author":"Matt","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2020.12.004_bib30","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41598-019-38634-3","article-title":"Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use","volume":"9","author":"Ishikawa","year":"2019","journal-title":"Sci Rep"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20307540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20307540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:29:44Z","timestamp":1761118184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20307540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1198743X20307540"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.12.004","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}